Skip to main content
. 2022 Mar 30;13:822362. doi: 10.3389/fneur.2022.822362

Figure 2.

Figure 2

Example of a multimodal trajectory planning targeting both contrast- and (fluorethyl)-L-tyrosine (FET)-enhancing areas in a case of a suspected recurrence of a multimodally treated oligodendroglioma, IDH mutated and 1p/19q co-deleted, the central nervous system (CNS) WHO grade 3. (Upper panel) Axial view of contrast enhanced T1, CT, FET positron emission tomography (PET), and T2. (Lower panel) Inline view depicting the trajectory plane.